The following amendment(s) has (have) been made to the 'Holding(s) in Company' announcement released on 25 May 2016 at 12.47 under RNS No 2919Z.
Additional information has been added to section 13 in relation to Christopher Mills, Non-Executive Chairman of EKF, who has an indirect beneficial interest in the shareholding that is subject to the below TR-1.
All other details remain unchanged.
The full amended text is shown below.
TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARESi
|
|
|
|||
1. Identity of the issuer or the underlying issuer |
EKF Diagnostics Holdings Plc |
|||
2 Reason for the notification (please tick the appropriate box or boxes): |
||||
An acquisition or disposal of voting rights |
YES |
|||
An acquisition or disposal of qualifying financial instruments which may result in the acquisition of shares already issued to which voting rights are attached |
|
|||
An acquisition or disposal of instruments with similar economic effect to qualifying financial instruments |
|
|||
An event changing the breakdown of voting rights |
|
|||
Other (please specify): |
|
|
||
3. Full name of person(s) subject to the |
Harwood Capital LLP (as investment adviser/manager) and North Atlantic Smaller Companies Investment Trust plc |
|||
4. Full name of shareholder(s) |
1. North Atlantic Smaller Companies Investment Trust PLC
2. Oryx International Growth Fund Limited
|
|||
5. Date of the transaction and date on |
20 MAY 2016 |
|||
6. Date on which issuer notified: |
24 MAY 2016 |
|||
7. Threshold(s) that is/are crossed or |
ABOVE 19% |
|||
8. Notified details: |
||||||||||||||||
A: Voting rights attached to shares viii, ix |
||||||||||||||||
Class/type of
|
Situation previous |
Resulting situation after the triggering transaction |
||||||||||||||
Number |
Number |
Number |
Number of voting |
% of voting rights x |
||||||||||||
Direct |
Direct xi |
Indirect xii |
Direct |
Indirect |
||||||||||||
GB0031509804 |
46,300,000
35,350,000
|
46,300,000
35,350,000
|
48,650,000
35,350,000
|
48,650,000
35,350,000
|
|
11.53%
8.38%
|
|
|||||||||
Holder 1:
Holder 2:
|
||||||||||||||||
|
||||||||||||||||
B: Qualifying Financial Instruments |
||||||||||||||||
Resulting situation after the triggering transaction |
||||||||||||||||
Type of financial |
Expiration |
Exercise/ |
Number of voting |
% of voting |
||||||||||||
|
|
|
|
|
||||||||||||
|
||||||||||||||||
C: Financial Instruments with similar economic effect to Qualifying Financial Instruments xv, xvi |
||||||||||||||||
Resulting situation after the triggering transaction |
||||||||||||||||
Type of financial |
Exercise price |
Expiration date xvii |
Exercise/ |
Number of voting rights instrument refers to
|
% of voting rights xix, xx
|
|||||||||||
|
|
|
|
|
Nominal |
Delta |
||||||||||
|
|
|||||||||||||||
|
||||||||||||||||
Total (A+B+C) |
||||||||||||||||
Number of voting rights |
Percentage of voting rights |
|||||||||||||||
84,00,000 |
19.90% |
|||||||||||||||
9. Chain of controlled undertakings through which the voting rights and/or the |
||
|
||
|
||
Proxy Voting: |
||
10. Name of the proxy holder: |
|
|
11. Number of voting rights proxy holder will cease to hold: |
|
|
12. Date on which proxy holder will cease to hold voting rights: |
|
|
|
||
|
Christopher Mills, Non-Executive Chairman of EKF, has an indirect beneficial interest in the above shares. He is a director of Oryx International Growth Fund Limited and North American Smaller Companies Investment Trust plc. He holds 2.16 percent. of the shares in Oryx International Growth Fund Limited in his own name and 46.44 per cent. via his 25.06 per cent. shareholding in North American Smaller Companies Investment Trust plc. The price paid for the shares is 11pence.
Harwood Capital LLP is investment manager to North Atlantic Smaller Companies Investment Trust plc and investment adviser to Oryx International Growth Fund Limited. Harwood Capital LLP is a limited liability partnership of which Christopher Mills is a partner and Chief Investment Officer. |
|
14. Contact name: |
Jane Muir |
|
15. Contact telephone number: |
0200 8819 6486 |
|